Qvella Corporation Revenue and Competitors

Richmond Hill, ON CAN

Location

$45.4M

Total Funding

Estimated Revenue & Valuation

  • Qvella Corporation's estimated annual revenue is currently $28.1M per year.(i)
  • Qvella Corporation's estimated revenue per employee is $251,000
  • Qvella Corporation's total funding is $45.4M.

Employee Data

  • Qvella Corporation has 112 Employees.(i)
  • Qvella Corporation grew their employee count by -23% last year.

Qvella Corporation's People

NameTitleEmail/Phone
1
IT SpecialistReveal Email/Phone
2
Senior Research AssociateReveal Email/Phone
3
Director, Cartridge DevelopmentReveal Email/Phone
4
Senior Research ScientistReveal Email/Phone
5
Sr QC AssociateReveal Email/Phone
6
Accounting ClerkReveal Email/Phone
7
Marketing Communications SpecialistReveal Email/Phone
8
Contract ManagerReveal Email/Phone
9
Product Application ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.1M124-4%N/AN/A
#2
$4M16-6%N/AN/A
#3
$78.3M3129%N/AN/A
#4
$23.1M926%N/AN/A
#5
$9.3M379%N/AN/A
#6
$75.3M2403%$53.9MN/A
#7
$267.6M106613%N/AN/A
#8
$36.6M0N/A$1.3BN/A
#9
$30.9M123-20%N/AN/A
#10
$8.5M34-17%N/AN/A
Add Company

What Is Qvella Corporation?

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

keywords:Food & Beverages,Healthcare,Medical Devices,Pharmaceuticals

$45.4M

Total Funding

112

Number of Employees

$28.1M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Qvella Corporation News

2022-04-13 - Qvella FAST System and FAST-PBC Prep Cartridge Get CE ...

During recent beta trials of Qvella's FAST System and FAST-PBC Prep Cartridge at renowned healthcare centers in ... About Qvella Corporation

2022-04-13 - Das Qvella FAST™ System und die FAST-PBC Prep ...

Qvella, ein Diagnostika-Anbieter, der die Zeit bis zum Vorliegen von Ergebnissen in der Mirobiologie verkürzen ... Über Qvella Corporation

2019-02-22 - HHS Expands Innovation Partnerships with Private Sector

This week DRIVe also announced a partnership with Qvella Corporation of Carlsbad, California, to develop technology that will diagnose ...

2019-01-03 - GeneCentric Therapeutics Appoints Michael V. Milburn, PhD ...

In addition to GeneCentric, Dr. Lai Goldman serves on the Board of Directors at West Pharmaceutical Services and Qvella Corporation as well ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.2M1122%N/A
#2
$23.4M1144%N/A
#3
$34.5M1198%N/A
#4
$18M1205%N/A
#5
$27.2M120N/AN/A